Ardelyx, Inc.

NasdaqGM:ARDX Stock Report

Market Cap: US$988.1m

Ardelyx Future Growth

Future criteria checks 5/6

Ardelyx is forecast to grow earnings and revenue by 59.3% and 19.2% per annum respectively. EPS is expected to grow by 59.7% per annum. Return on equity is forecast to be 50% in 3 years.

Key information

59.3%

Earnings growth rate

59.7%

EPS growth rate

Biotechs earnings growth23.7%
Revenue growth rate19.2%
Future return on equity50.0%
Analyst coverage

Good

Last updated02 May 2025

Recent future growth updates

Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Nov 03
Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Aug 04
Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

May 04
Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Recent updates

Ardelyx: Revenue Misses And Losses Widen Amid XPHOZAH Uncertainty

May 02
author-image

Omnichannel Investments And Sales Teams Will Create Future IBSRELA Demand

Apr 27 Strategic investments and an expanded sales team are expected to drive demand for IBSRELA, boosting revenue and market share.

Ardelyx: Limited Pipeline, Rising Costs, And Uncertain Growth Ahead (Downgrade)

Feb 24

There's No Escaping Ardelyx, Inc.'s (NASDAQ:ARDX) Muted Revenues

Feb 17
There's No Escaping Ardelyx, Inc.'s (NASDAQ:ARDX) Muted Revenues

Ardelyx: A Small Bet Its Latest Setback Will Be Temporary

Dec 20

Ardelyx Lost The Lawsuit, But The Kidney PATIENT Act Will Save It

Nov 24

Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability

Nov 14

Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Nov 03
Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Ardelyx, Inc.'s (NASDAQ:ARDX) Shares Lagging The Industry But So Is The Business

Oct 24
Ardelyx, Inc.'s (NASDAQ:ARDX) Shares Lagging The Industry But So Is The Business

Is Ardelyx (NASDAQ:ARDX) Weighed On By Its Debt Load?

Aug 25
Is Ardelyx (NASDAQ:ARDX) Weighed On By Its Debt Load?

Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts

Aug 07
Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts

Ardelyx Faces Rising Challenges Despite Revenue Growth

Aug 05

Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Aug 04
Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Ardelyx: Increased Focus On Ibsrela Due To Xphozah's Uncertain Outlook

Jul 13

Why Investors Shouldn't Be Surprised By Ardelyx, Inc.'s (NASDAQ:ARDX) 25% Share Price Plunge

Jul 05
Why Investors Shouldn't Be Surprised By Ardelyx, Inc.'s (NASDAQ:ARDX) 25% Share Price Plunge

Ardelyx: Strong Execution, Fairly Valued

May 10

Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

May 04
Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Ardelyx Stock: A Crowded Market Curbs The Enthusiasm (Rating Downgrade)

May 03

Ardelyx, Inc.'s (NASDAQ:ARDX) Popularity With Investors Is Under Threat From Overpricing

Apr 17
Ardelyx, Inc.'s (NASDAQ:ARDX) Popularity With Investors Is Under Threat From Overpricing

Ardelyx Shrugs Off 'Mixed' Q4 Earnings

Mar 13

Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Feb 24
Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Ardelyx Q4 Preview: Recent Bull Run May Pause While Market Digests 2024 Guidance

Feb 20

Ardelyx's XPHOZAH Still An Afterthought To The Pros

Jan 31

Ardelyx: FDA Approval For Xphozah Grants Further Sales Enhancement

Jan 10

Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price

Jan 04
Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price

Despite Lacking Profits Ardelyx (NASDAQ:ARDX) Seems To Be On Top Of Its Debt

Dec 14
Despite Lacking Profits Ardelyx (NASDAQ:ARDX) Seems To Be On Top Of Its Debt

Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts

Aug 03
Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts

Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt

Jul 31
Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt

Pinning Down Ardelyx, Inc.'s (NASDAQ:ARDX) P/S Is Difficult Right Now

Apr 17
Pinning Down Ardelyx, Inc.'s (NASDAQ:ARDX) P/S Is Difficult Right Now

Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?

Mar 30
Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?

Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?

Dec 14
Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?

Earnings and Revenue Growth Forecasts

NasdaqGM:ARDX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20276191662412338
12/31/2026486321047710
12/31/2025369-91-41-5910
3/31/2025362-54-49-48N/A
12/31/2024334-39-46-45N/A
9/30/2024252-73-64-63N/A
6/30/2024210-65-86-85N/A
3/31/2024159-66-81-81N/A
12/31/2023124-66-90-90N/A
9/30/2023134-27-67-67N/A
6/30/202383-56-71-71N/A
3/31/202363-66-87-87N/A
12/31/202252-67-70-70N/A
9/30/20229-114-124-124N/A
6/30/20225-135-133-133N/A
3/31/20224-153-137-136N/A
12/31/202110-158-154-153N/A
9/30/202111-151-133-131N/A
6/30/202112-125-118-116N/A
3/31/202113-105-102-101N/A
12/31/20208-94-82-81N/A
9/30/20208-85-75-75N/A
6/30/20208-91-76-76N/A
3/31/20206-91-85-85N/A
12/31/20195-95-77-76N/A
9/30/20193-103-84-84N/A
6/30/20190-104-91-90N/A
3/31/20190-100-81-80N/A
12/31/20183-91N/A-70N/A
9/30/201845-53N/A-47N/A
6/30/201844-50N/A-39N/A
3/31/201844-53N/A-45N/A
12/31/201742-64N/A-65N/A
9/30/2017N/A-106N/A-97N/A
6/30/2017N/A-114N/A-102N/A
3/31/2017N/A-117N/A-103N/A
12/31/2016N/A-112N/A-93N/A
9/30/2016N/A-98N/A-87N/A
6/30/2016N/A-87N/A-75N/A
3/31/201618-50N/A-80N/A
12/31/201524-30N/A-72N/A
9/30/201530-16N/A-54N/A
6/30/2015382N/A-48N/A
3/31/201529-6N/A6N/A
12/31/201432-3N/A13N/A
9/30/201434-4N/A28N/A
6/30/201433-5N/A34N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ARDX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.8%).

Earnings vs Market: ARDX is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ARDX is expected to become profitable in the next 3 years.

Revenue vs Market: ARDX's revenue (19.2% per year) is forecast to grow faster than the US market (8.5% per year).

High Growth Revenue: ARDX's revenue (19.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ARDX's Return on Equity is forecast to be very high in 3 years time (50%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/04 02:09
End of Day Share Price 2025/05/02 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ardelyx, Inc. is covered by 20 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Julian HarrisonBTIG
Mara GoldsteinCantor Fitzgerald & Co.
Louise ChenCantor Fitzgerald & Co.